相关实验视频

Updated: Jul 15, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

在人类受试者中阻断抗体反应,这些受试者受到一种新的雪山病毒 (Inoculum) 的挑战

Makoto Ibaraki¹, Lilin Lai², Christopher Huerta¹

¹Emory University.

Research square

|October 4, 2023

概括

诺罗病毒 (NoV) 挑战研究表明,在雪山病毒 (SMV) 挑战后产生了对血组抗原 (HBGA) 阻断抗体. 这些阻断抗体在挑战后的45天内仍然可检测,这表明SMV注射剂.

科学领域:

病毒学和免疫学病毒学和免疫学
胃肠病学胃肠病学

背景情况:

诺罗病毒 (NoVs) 引起广泛的胃肠炎;雪山病毒 (SMV) 是人类挑战模型中使用的GII.2原型.
阻断抗体抑制病毒样粒子 (VLP) 结合基因组抗原 (HBGAs) 对诺沃克病毒和GII.4至关重要,但它们在SMV中的作用不明.

结论:

基因组抗原 (HBGA) 阻断抗体的几何平均标位 (GMT) 在SMV挑战后被诱导.
阻塞抗体持续存在并可检测到SMV挑战后的45天.
第二代SMV注射剂在引起抗体反应方面表现出高效.

关键词:

诺罗病毒是诺罗病毒.雪山病毒雪山病毒封锁抗体的抗体这是人类面临的挑战.

更多相关视频

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Measuring Influenza Neutralizing Antibody Responses to AH3N2 Viruses in Human Sera by Microneutralization Assays Using MDCK-SIAT1 Cells

Published on: November 22, 2017

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Cross-reactivity

Cross-reactivity